Raising the bar in ulcerative colitis management
Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Ferdinando D’Amico · 2024
Read Raising the bar in ulcerative colitis management by Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Ferdinando D’Amico (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11589388.txt.
Description
Ulcerative colitis, a long-running inflammation of the colon, is becoming more common worldwide, and its drug shelf keeps growing. Fabrizio Fanizzi and co-authors review how doctors should aim higher in managing the disease. With many new molecules and no single ranking guide, choosing and ordering drugs is a clinical puzzle.
The review favors a treat-to-target strategy: pick measurable goals and adjust therapy until they are met. Beyond symptoms and scope findings, newer targets include tissue healing, ultrasound signs, and molecular markers. Care is also growing more personal, shaped to each patient's profile. For patients who still do not reach remission, pairing two targeted drugs is an emerging option. The authors chart how these pieces fit into modern practice.
Catalog record
| CREATOR | Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Ferdinando D’Amico |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 98 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |